# Optimal Timing for Expanding Diagnostic Laboratories, South Korea

**Authors:** Jae-Sun Park, Gab Jung Kim, Sang Won Lee

PMC · DOI: 10.3201/eid3108.241745 · Emerging Infectious Diseases · 2025-08-01

## TL;DR

South Korea's rapid expansion of diagnostic labs during the early stages of the pandemic highlights the importance of timely and proactive testing strategies in managing infectious diseases.

## Contribution

The paper emphasizes the importance of timely expansion of testing capacity and learning from past outbreaks to improve future responses.

## Key findings

- South Korea's early expansion of testing capacity was crucial in managing the initial stages of the pandemic.
- Expanding testing to private labs was a key difference in the response to the pandemic compared to previous outbreaks.
- Proactive and well-timed preparedness is essential for effective responses to emerging infectious diseases.

## Abstract

The rapid expansion of testing capacity is imperative for an adequate response to infectious diseases, such as COVID-19. South Korea rapidly secured large-scale testing during the early stages of COVID-19 in 2020 by leveraging the country’s experience with the 2015 Middle East respiratory syndrome outbreak; the initial response was relatively successful. A key difference between the 2 outbreak responses was the expansion from public to private testing laboratories during the COVID-19 pandemic. Expanding testing capacity during an infectious disease crisis should involve consideration of the overall response system and social conditions and not just the number of patients. If there are concerns about a crisis developing, testing capacity expansion should begin as soon as possible. Furthermore, accuracy should be ensured, especially when testing capacity is expanded. South Korea’s experience in developing diagnostic systems and adopting testing strategies underscores the value of proactive and well-timed preparedness for emerging infection disease outbreaks.

## Linked entities

- **Diseases:** Middle East respiratory syndrome (MONDO:0100116), COVID-19 (MONDO:0100096)

## Full-text entities

- **Diseases:** COVID-19 (MESH:D000086382), infectious disease (MESH:D003141), infection disease (MESH:D007239), Middle East respiratory syndrome (MESH:D018352)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12309759/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12309759/full.md

## References

11 references — full list in the complete paper: https://tomesphere.com/paper/PMC12309759/full.md

---
Source: https://tomesphere.com/paper/PMC12309759